Concurrent 7B: HIV and Other Infectious Diseases
Tracks
.
Friday, October 11, 2024 |
2:15 PM - 3:30 PM |
Nikos Skalkotas Hall |
Speaker
Professor Peter Vickerman
Professor Of Infectious Disease Modelling
University of Bristol
Impact of scaling up harm reduction interventions on injecting risk behaviours, HIV incidence and ART outcomes among people who inject drugs in Kenya
2:15 PM - 2:30 PMBiography
Peter Vickerman is a Professor in infectious disease modelling. His research focuses on using modelling and epidemiological analyses to assess the transmission of infectious diseases and impact/cost-effectiveness of prevention measures amongst different populations, especially among groups particularly vulnerable to HIV and HCV in low- and middle-income countries.
Ms Carol El-Hayek
Epidemiologist
Burnet Institute
EVALUATING A MACHINE LEARNING-BASED RISK STRATIFICATION MODEL TO IDENTIFY PEOPLE WHO HAVE INJECTED DRUGS FOR THE SURVEILLANCE OF BLOOD BORNE VIRUSES AND SEXUALLY TRANSMISSIBLE INFECTIONS
2:30 PM - 2:45 PMBiography
Carol El-Hayek is an epidemiologist and informatician with over a decade's experience managing BBV/STI surveillance systems and evaluating health promotion programs. Carol has recently completed a PhD exploring the use of machine learning to enhance the methods used to analyze clinical data for surveillance purposes.
Prof Ravi Goyal
Assistant Professor
University Of California San Diego
INVESTIGATING HIV MIXING BY INJECTION DRUG USE STATUS IN MIAMI USING A NOVEL APPROACH FOR BAYESIAN INFERENCE ON PARTIALLY OBSERVED MOLECULAR NETWORKS
2:45 PM - 3:00 PMBiography
Ravi Goyal, PhD, is an Assistant Professor at UC San Diego. Dr. Goyal’s research interests lie at the intersection of statistics, network science, and public health. His research contributions have been the development of statistical methods and their application to design and assess the impact of public health interventions.
MD. PhD Martin Kåberg
MD, PhD
Stockholm Centre for Dependency Disorders
HIV AMONG PEOPLE WHO INJECT DRUGS IN STOCKHOLM, SWEDEN – PREVALENCE, INCIDENS AND TREATMENT OUTCOMES
3:00 PM - 3:05 PMBiography
Martin Kåberg (MK) is a Senior Consultant of Psychiatry/Addiction Medicine and Infectious Diseases at Stockholm Center for Dependency Disorders. MK is the medical supervisor for the Stockholm Needle and Syringe Programs. MK is a senior researcher at Karolinska Instititutet, Department of Global Public Health, Stockholm, Sweden.
Dr Matt Akiyama
Associate Professor of Medicine
Department of Medicine, Albert Einstein College of Medicine / Montefiore Medical Centre, New York, USA
DIFFERENTIAL RISK FOR HCV AND HIV AMONG PEOPLE WHO INJECT DRUGS IN KENYA: A LATENT CLASS ANALYSIS SIGNALING NEEDS FOR INNOVATION IN SERVICE DELIVERY
3:05 PM - 3:10 PMBiography
Dr. Akiyama is a clinician-investigator at Albert Einstein College of Medicine. In addition to providing care to people with HCV, HIV, and substance use disorders, Dr. Akiyama conducts research on models of care in resource limited settings with an emphasis on people who use drugs and the criminal legal system.
Dr Aaron Lim
Lecturer in Infectious Disease Mathematical Modelling
University of Bristol
ESTIMATING THE IMPACT OF EXISTING HARM REDUCTION INTERVENTIONS ON HIV INCIDENCE AMONG PWID IN MYANMAR: A MODELLING STUDY
3:10 PM - 3:15 PMBiography
I am an infectious disease mathematical modeller interested in global health, especially in low- and middle-income countries. My recent modelling work has focussed on developing dynamic transmission models to evaluate the impact and cost-effectiveness of interventions for HCV and HIV epidemics in the general population and people who inject drugs.
Ms Marina Plesons
Md Phd Candidate
University Of Miami Miller School Of Medicine
Ms Sarah Tran
Clinical Research Analyst
VIRCAN
UTILIZING SELF-COLLECTION DRIED BLOOD SPOT TO INCREASE ACCESSIBILITY TO HEPATITIS C, HEPATITIS B AND COVID-19 TESTING
3:20 PM - 3:25 PMBiography
Sarah Sousa Tran is a Clinical Research Analyst at the Viral Hepatitis Care Network at University Health Network’s Toronto Centre for Liver Disease in Toronto, Canada. She has worked on several hepatitis C research studies, as well as outreach initiatives, testing community members for HCV through POC testing.
Mrs Martha Papadopoulou
Nurse
First Department Of Internal Medicine, Laiko General Hospital, National And Kapodistrian University Of Athens
HIV CARE CONTINUUM AMONG PEOPLE WHO INJECT DRUGS (PWID) IN ATHENS: LINKAGE AND RETENTION RATES (PRELIMINARY FINDINGS)
3:25 PM - 3:30 PMBiography
Martha Papadopoulou is a nurse and a PhD candidate at the Medical School, National and Kapodistrian University of Athens. Her main research focuses on populations at risk for HCV and HIV/AIDS. She served as the head nurse of a study, which explored the feasibility and impact of a public health system Pre-Exposure Prophylaxis (PrEP) intervention in the recently emerging HIV epidemic in Athens
Chairperson
Shashi N Kapadia
Assistant Professor of Medicine
Weill Cornell Medicine
